(Q54638471)
Statements
Long-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's disease. (English)
R Inzelberg
P Nisipeanu
M J Rabey
1 September 1995
10
5
604-607
scientific article